Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wild

Showing results (681-690 of 738) with videos related to

Pageof 74
Sort By:
Diagnostics (Basel, Switzerland)|May 13, 2023
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Mattia Luca Piccinelli, et al.
Science Translational Medicine|December 17, 2020
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's diseaseFilipe B Rodrigues, Lauren M Byrne, Rosanna Tortelli, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
Pathology, Research and Practice|May 30, 2018
Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencingQing Zhong, Ulrich Wagner, Henriette Kurt, et al.
Oncogene|January 18, 2019
Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repairMarcos Seoane, Sophia Buhs, Pablo Iglesias, et al.
Nature Communications|July 2, 2025
Cell-specific mechanisms drive connectivity across the time course of Huntington's diseaseCarlos Estevez-Fraga, Isaac Sebenius, Justine Y Hansen, et al.
European Urology|April 16, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, et al.
The Journal of Experimental Medicine|August 5, 2020
AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancerJulia Varga, Adele Nicolas, Valentina Petrocelli, et al.
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
Pageof 74

Showing results (681-690 of 738) with videos related to

Sort By:
Pageof 74
Diagnostics (Basel, Switzerland)|May 13, 2023
External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Mattia Luca Piccinelli, et al.
Science Translational Medicine|December 17, 2020
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's diseaseFilipe B Rodrigues, Lauren M Byrne, Rosanna Tortelli, et al.
European Urology|January 2, 2008
Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyMaximilian Burger, Madelon N M van der Aa, Johanna M M van Oers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 21, 2009
Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysisPeter J Wild, Thomas Fuchs, Robert Stoehr, et al.
Pathology, Research and Practice|May 30, 2018
Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencingQing Zhong, Ulrich Wagner, Henriette Kurt, et al.
Oncogene|January 18, 2019
Lineage-specific control of TFIIH by MITF determines transcriptional homeostasis and DNA repairMarcos Seoane, Sophia Buhs, Pablo Iglesias, et al.
Nature Communications|July 2, 2025
Cell-specific mechanisms drive connectivity across the time course of Huntington's diseaseCarlos Estevez-Fraga, Isaac Sebenius, Justine Y Hansen, et al.
European Urology|April 16, 2013
Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08)Arnoud J Templeton, Valérie Dutoit, Richard Cathomas, et al.
The Journal of Experimental Medicine|August 5, 2020
AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancerJulia Varga, Adele Nicolas, Valentina Petrocelli, et al.
Journal of Cancer|March 7, 2017
Immunohistochemical and molecular characterizations in urothelial carcinoma of bladder in patients less than 45 yearsVeronika Weyerer, Roland Schneckenpointner, Thomas Filbeck, et al.
Pageof 74